(Elastography) E-BI-RADS: A Novel Classification System for Breast Elastography to Enable Safe Biopsy De-escalation

OBJECTIVES: Determining the probability of malignancy of a breast lesion allows for the appropriate triage of follow-up. Although BI-RADS provides standardized risk stratification for mammography, ultrasound, and magnetic resonance imaging, no equivalent classification system exists for breast elastography. The aim of this study was to develop and evaluate a data-driven E-BI-RADS classification for breast elastography and to compare its diagnostic performance with B-mode BI-RADS. MATERIALS AND METHODS: In this retrospective study, consecutive patients undergoing breast imaging with available B-mode ultrasound, shear-wave elastography (SWE), and strain elastography (10L4 transducer, Siemens ACUSON Sequoia) from 06/2023 to 12/2025 were included. A multivariable logistic regression model combining SWE velocity and elastography-to-B-mode lesion size (E/B) ratio was used to estimate malignancy probability, followed by Platt recalibration. Data-driven probability cutoffs were derived to define E-BI-RADS categories aligned with the BI-RADS concept. (E-)BI-RADS categories 4 and 5 were considered an indication for biopsy. Histopathologic evaluation or imaging follow-up served as the reference standard. RESULTS: The cohort comprised 344 breast lesions in 337 patients, including 224 (65.1%) malignant and 120 (34.9%) benign lesions. B-mode BI-RADS achieved a sensitivity of 98.6% (221/224) and a specificity of 34.2% (41/120). E-BI-RADS demonstrated malignancy rates of 0.0% in E-BI-RADS 2 (0/71); 5.3% in E-BI-RADS 3 (1/19); 85.2% in E-BI-RADS 4 (155/182); and 94.4% in E-BI-RADS 5 (68/70). E-BI-RADS achieved a sensitivity of 99.6% (223/224) and a specificity of 74.2% (89/120). The single false-negative case was a 31 mm B-cell lymphoma, classified as E-BI-RADS 3, with a shear-wave velocity of 4.4 m/s and an E/B ratio of 0.9. Decision-curve analysis demonstrates that E-BI-RADS achieves higher net benefit than SWE-based and B-mode BI-RADS strategies. DISCUSSION: E-BI-RADS provides the first standardized, BI-RADS-like classification system for breast elastography and enables safe biopsy de-escalation with excellent sensitivity and improved specificity compared with existing approaches.

Authors

Institutions

Publication Details

Journal
Investigative Radiology
Published
2026-11-12
DOI
https://doi.org/10.1097/rli.0000000000001318
Primary Topic
Ultrasound Imaging and Elastography
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

(Elastography) E-BI-RADS: A Novel Classification System for Breast Elastography to Enable Safe Biopsy De-escalation

Christopher Mamone, Parker Bauman, Michael Golatta, R. Graham Barr et al.
Investigative Radiology
Ultrasound Imaging and Elastography
article

(Elastography) E-BI-RADS: A Novel Classification System for Breast Elastography to Enable Safe Biopsy De-escalation

Christopher Mamone, Parker Bauman, Michael Golatta, R. Graham Barr, André Pfob, Kevin Chang
article en

Abstract

OBJECTIVES: Determining the probability of malignancy of a breast lesion allows for the appropriate triage of follow-up. Although BI-RADS provides standardized risk stratification for mammography, ultrasound, and magnetic resonance imaging, no equivalent classification system exists for breast elastography. The aim of this study was to develop and evaluate a data-driven E-BI-RADS classification for breast elastography and to compare its diagnostic performance with B-mode BI-RADS. MATERIALS AND METHODS: In this retrospective study, consecutive patients undergoing breast imaging with available B-mode ultrasound, shear-wave elastography (SWE), and strain elastography (10L4 transducer, Siemens ACUSON Sequoia) from 06/2023 to 12/2025 were included. A multivariable logistic regression model combining SWE velocity and elastography-to-B-mode lesion size (E/B) ratio was used to estimate malignancy probability, followed by Platt recalibration. Data-driven probability cutoffs were derived to define E-BI-RADS categories aligned with the BI-RADS concept. (E-)BI-RADS categories 4 and 5 were considered an indication for biopsy. Histopathologic evaluation or imaging follow-up served as the reference standard. RESULTS: The cohort comprised 344 breast lesions in 337 patients, including 224 (65.1%) malignant and 120 (34.9%) benign lesions. B-mode BI-RADS achieved a sensitivity of 98.6% (221/224) and a specificity of 34.2% (41/120). E-BI-RADS demonstrated malignancy rates of 0.0% in E-BI-RADS 2 (0/71); 5.3% in E-BI-RADS 3 (1/19); 85.2% in E-BI-RADS 4 (155/182); and 94.4% in E-BI-RADS 5 (68/70). E-BI-RADS achieved a sensitivity of 99.6% (223/224) and a specificity of 74.2% (89/120). The single false-negative case was a 31 mm B-cell lymphoma, classified as E-BI-RADS 3, with a shear-wave velocity of 4.4 m/s and an E/B ratio of 0.9. Decision-curve analysis demonstrates that E-BI-RADS achieves higher net benefit than SWE-based and B-mode BI-RADS strategies. DISCUSSION: E-BI-RADS provides the first standardized, BI-RADS-like classification system for breast elastography and enables safe biopsy de-escalation with excellent sensitivity and improved specificity compared with existing approaches.

Investigative Radiology
Heidelberg University (DE), University Hospital Heidelberg (DE), Northeast Ohio Medical University (US)
Good health and well-being
Ultrasound Imaging and Elastography
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon